AWHL Aspira Womens Health Inc Ordinary Shares revenue, earnings and financials
For the quarter ended June 30, 2026, Aspira Womens Health Inc Ordinary Shares reported revenue of $17.0K (down 89.9% from a year earlier), net income of −$2.42M and diluted EPS of −$0.05; over the last four quarters revenue was $223K and net income $2.76M; for the fiscal year ended December 2025 revenue was $343K, up 8475.0% on the year before.
AWHL annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $343K, gross profit $5.92M, operating income −$7.91M, net income −$12.8K (margin -3.7%), EPS −$0.37
- Fiscal year ended Dec 2024: revenue $4.00K, gross profit $5.48M, operating income −$16.3M, net income −$13.1K (margin -327.4%), EPS −$0.93
- Fiscal year ended Dec 2023: revenue $87.0M, gross profit $5.26M, operating income −$18.9M, net income −$17.0K (margin 0.0%), EPS −$1.81
- Fiscal year ended Dec 2022: revenue $8.18M, gross profit $4.32M, operating income −$31.1M, net income −$29.9M (margin -365.2%), EPS −$3.85
- Fiscal year ended Dec 2021: revenue $6.81M, gross profit $3.06M, operating income −$32.6M, net income −$31.7M (margin -464.8%), EPS −$4.27
AWHL quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $17.0K (down 89.9% year over year), net income −$2.42M, EPS −$0.05
- Quarter ended Mar 31, 2026: revenue $32.0K, net income $676K, EPS −$0.05
- Quarter ended Dec 31, 2025 (from the annual report): revenue $85.0K (up 101.2% year over year), net income $9.40M, EPS −$0.08
- Quarter ended Sep 30, 2025: revenue $89.0K (down 96.1% year over year), net income −$4.89M, EPS −$0.13
- Quarter ended Jun 30, 2025: revenue $169K (down 93.0% year over year), net income −$2.67M, EPS −$0.07
- Quarter ended Mar 31, 2025: revenue $0 (down 100.0% year over year), net income −$1.85M, EPS −$0.09
- Quarter ended Dec 31, 2024 (from the annual report): revenue −$6.83M (down 108.5% year over year), net income $11.7M, EPS −$0.03
- Quarter ended Sep 30, 2024: revenue $2.26M (up 1.8% year over year), net income −$3.55M, EPS −$0.23
- Quarter ended Jun 30, 2024: revenue $2.42M (down 2.7% year over year), net income −$3.53M, EPS −$0.28
- Quarter ended Mar 31, 2024: revenue $2.15M (down 7.0% year over year), net income −$4.63M, EPS −$0.39
- Quarter ended Dec 31, 2023 (from the annual report): revenue $80.0M (up 3614.6% year over year), net income $13.6M, EPS −$0.26
- Quarter ended Sep 30, 2023: revenue $2.22M (up 7.0% year over year), net income −$4.71M, EPS −$0.48
- Quarter ended Jun 30, 2023: revenue $2.49M (up 20.6% year over year), net income −$2.32M, EPS −$0.28
- Quarter ended Mar 31, 2023: revenue $2.32M (up 22.3% year over year), net income −$6.58M, EPS −$0.79
- Quarter ended Dec 31, 2022 (from the annual report): revenue $2.15M (up 16.3% year over year), net income −$4.59M, EPS −$0.51
- Quarter ended Sep 30, 2022: revenue $2.07M (up 24.4% year over year), net income −$7.78M, EPS −$1.00
- Quarter ended Jun 30, 2022: revenue $2.07M (up 14.8% year over year), net income −$8.24M, EPS −$1.10
- Quarter ended Mar 31, 2022: revenue $1.89M (up 26.5% year over year), net income −$9.27M, EPS −$1.24
- Quarter ended Dec 31, 2021 (from the annual report): revenue $1.85M, net income −$8.96M, EPS −$4.07
- Quarter ended Sep 30, 2021: revenue $1.67M, net income −$9.71M, EPS −$0.09
AWHL cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$7.03M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$12.1M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$15.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$31.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$27.4M, share buybacks n/a
AWHL balance sheet
- Jun 30, 2026: cash $477K, total assets $4.44M, total liabilities $11.7M, shareholders' equity −$7.26M, long-term debt $961K
- Mar 31, 2026: cash $1.34M, total assets $5.09M, total liabilities $11.3M, shareholders' equity −$6.21M, long-term debt $980K
- Dec 31, 2025: cash $1.76M, total assets $5.46M, total liabilities $12.4M, shareholders' equity −$6.93M, long-term debt $1.04M
- Sep 30, 2025: cash $3.81M, total assets $7.30M, total liabilities $11.6M, shareholders' equity −$4.34M, long-term debt $1.10M
- Jun 30, 2025: cash $1.55M, total assets $4.93M, total liabilities $7.62M, shareholders' equity −$2.69M, long-term debt $1.16M
- Mar 31, 2025: cash $3.31M, total assets $6.72M, total liabilities $6.78M, shareholders' equity −$60.0K, long-term debt $1.22M
- Dec 31, 2024: cash $1.77M, total assets $5.49M, total liabilities $8.05M, shareholders' equity −$2.56M, long-term debt $1.28M
- Sep 30, 2024: cash $2.13M, total assets $4.76M, total liabilities $7.28M, shareholders' equity −$2.52M, long-term debt $1.33M
What is AWHL's revenue?
Aspira Womens Health Inc Ordinary Shares reported $223K of revenue over its last four quarters, through June 30, 2026.
Is AWHL profitable?
Yes. Aspira Womens Health Inc Ordinary Shares earned $2.76M over the last four quarters.
What is AWHL's EPS?
Diluted earnings per share over the last four quarters were −$0.31; −$0.05 in the latest quarter.